[
  {
    "criterion": "Provides a definitive and up-to-date consensus on dual antiplatelet therapy duration for patients with drug-eluting stents.",
    "axis": "accuracy",
    "point": 8
  },
  {
    "criterion": "Advises the cardiologist to consult specific guidelines or research papers for the most up-to-date information on dual antiplatelet therapy.",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Provides a clear and concise explanation of the benefits and risks of different dual antiplatelet therapy durations for patients with drug-eluting stents.",
    "axis": "communication_quality",
    "point": 7
  },
  {
    "criterion": "Fails to address the cardiologist's concern about conflicting guidelines on dual antiplatelet therapy duration.",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Incorrectly states that there is a universal consensus on dual antiplatelet therapy duration for patients with drug-eluting stents.",
    "axis": "accuracy",
    "point": -9
  },
  {
    "criterion": "Provides a general overview of dual antiplatelet therapy but fails to address the specific concern about conflicting guidelines.",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "Asks the cardiologist to clarify their question or provide more context about the patient's condition.",
    "axis": "context_awareness",
    "point": 4
  },
  {
    "criterion": "Advises the cardiologist to consult with a colleague or seek additional information before making a decision.",
    "axis": "instruction_following",
    "point": 6
  },
  {
    "criterion": "Provides a detailed explanation of the science behind dual antiplatelet therapy and its effects on patients with drug-eluting stents.",
    "axis": "communication_quality",
    "point": 8
  }
]